Info

Celera Corporation (Celera) is a healthcare business delivering personalized disease management through a combination of products and services. The Company operates in three segments: a clinical laboratory testing service business (Lab Services), a products business (Products), and a segment which includes other activities under corporate management (Corporate). Its Lab Services business, conducted through Berkeley HeartLab, Inc., (BHL), offers a portfolio of clinical laboratory tests and disease management services to help healthcare providers improve cardiovascular disease treatment regimens for patients. Its Products business develops, manufactures, and oversees the commercialization of molecular diagnostic products, which are commercialized through its relationship with Abbott Molecular, a subsidiary of Abbott Laboratories. On July 1, 2008, Celera announced that it has completed its split-off from Applera Corporation.(Source: 10-K)